A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011101 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Emily Hsieh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, United States of America. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, HIV Seropositivity. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Transcriptional silencing of latent HIV-1 proviruses entails complex and overlapping mechanisms that pose a major barrier to in vivo elimination of HIV-1. We developed a new latency CRISPR screening strategy, called Latency HIV-CRISPR which uses the packaging of guideRNA-encoding lentiviral vector genomes into the supernatant of budding virions as a direct readout of factors involved in the maintenance of HIV-1 latency. We developed a custom guideRNA library targeting epigenetic regulatory genes and paired the screen with and without a latency reversal agent–AZD5582, an activator of the non-canonical NFκB pathway–to examine a combination of mechanisms controlling HIV-1 latency. A component of the Nucleosome Acetyltransferase of H4 histone acetylation (NuA4 HAT) complex, ING3, acts in concert with AZD5582 to activate proviruses in J-Lat cell lines and in a primary CD4+ T cell model of HIV-1 latency. We found that the knockout of ING3 reduces acetylation of the H4 histone tail and BRD4 occupancy on the HIV-1 LTR. However, the combination of ING3 knockout accompanied with the activation of the non-canonical NFκB pathway via AZD5582 resulted in a dramatic increase in initiation and elongation of RNA Polymerase II on the HIV-1 provirus in a manner that is nearly unique among all cellular promoters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, United States of America.
- Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
- Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
- Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
- Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
ORCID-Profile: Michael Emerman
Förderung
- NIDA NIH HHS
- NIAID NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- National Institute on Drug Abuse
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Hsieh, E., Janssens, D. H., Paddison, P. J., Browne, E. P., Henikoff, S., OhAinle, M., & Emerman, M. (2023). A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011101
Vancouver
Hsieh E, Janssens DH, Paddison PJ, Browne EP, Henikoff S, OhAinle M, et al. A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011101
BibTeX
@article{Hsieh2023,
author = {Hsieh, Emily and Janssens, Derek H and Paddison, Patrick J and Browne, Edward P and Henikoff, Steve and OhAinle, Molly and Emerman, Michael},
title = {A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011101}
}
EUVIMED